Relay Therapeutics (RLAY) is a clinical-stage precision medicines company focused on targeted oncology, with a $4.4 billion market cap. RLAY has surged 486% over the past year. Shares are trading near...
Achieve Life Sciences (ACHV) is a $685 million biotech focused on cytisinicline-based nicotine addiction treatments, showing strong recent technical momentum. ACHV has surged 173% over 52 weeks. Shares...
TrueBlue (TBI) is a leading workforce solutions provider, recently achieving strong technical momentum and a 2-year high of $10.73. TBI has gained 80% over the past year. Revenue is forecast to grow 8.10%...
CareDx (CDNA) has surged 300% over the past year, driven by robust technical momentum and strong buy signals. CDNA is rated a “Strong Buy” by several analysts, with consensus price targets suggesting...
Brinker International (EAT) demonstrates strong technical momentum, with a 40% gain over the past year. EAT trades at a trailing P/E of 22.18x, with revenue and earnings expected to grow 7.82% and 20.92%...
Lindblad Expeditions (LIND) demonstrates exceptional momentum, gaining 160% over the past year. Shares recently hit a new all-time high. LIND holds a 100% “Buy” technical opinion from Barchart and...
Corcept Therapeutics (CORT) demonstrates exceptional price momentum with shares up more than 50% over the past year. CORT’s fundamentals are robust with revenue and earnings both projected to grow...
Anterix (ATEX) has surged 380% over the past year, recently hitting an all-time high of $113. ATEX maintains strong technical momentum with a 100% “Buy” rating from Barchart. Revenue is forecast to...
Liquidia (LQDA) exhibits exceptional momentum with shares up more than 360% over the past 52 weeks. LQDA holds a 100% “Buy” technical opinion, with multiple analyst ratings supporting strong bullish...
Victoria’s Secret (VSXY) has surged 355% over the past year, driven by strong technical momentum. Shares are trading at a new all-time high. Valuation appears stretched at a 30.52x trailing price-earnings...
